Ganoderma lucidum protects dopaminergic neuron degeneration through inhibition of microglial activation

Evidence-based Complementary and Alternative Medicine

Volumn 2011, Issue , 2011, Pages

  Chan, Piu ^a   Zhang, Ruiping ^a   Xu, Shengli ^a   Cai, Yanning ^a   Zhou, Ming ^a   Zuo, Xiaohong ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GANODERMA LUCIDUM EXTRACT; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL ACTIVATION; CELL ISOLATION; CYTOKINE RELEASE; DOPAMINERGIC NERVE CELL; DOPAMINERGIC NEURON DEGENERATION; DOWN REGULATION; GANODERMA LUCIDUM; IMMUNOCYTOCHEMISTRY; LOW DRUG DOSE; MICROGLIA; NERVE CELL DEGENERATION; NEUROPROTECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 80052768762     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1093/ecam/nep075     Document Type: Article

References (46)

1. Parkinson J., An essay on the shaking palsy The Journal of Neuropsychiatry and Clinical Neurosciences 2002 14 2 223 222
2. Dawson T. M., Dawson V. L., Neuroprotective and neurorestorative strategies for Parkinson's disease Nature Neuroscience 2002 5 supplement 1058 1061 (Pubitemid 35247199)
3. Kreutzberg G. W., Microglia: a sensor for pathological events in the CNS Trends in Neurosciences 1996 19 8 312 318 (Pubitemid 26349059)
4. Miller G., Neuroscience. The dark side of glia Science 2005 308 778 781
5. McGeer P. L., Itagaki S., Boyes B. E., McGeer E. G., Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains Neurology 1988 38 8 1285 1291
6. Tansey M. G., McCoy M. K., Frank-Cannon T. C., Neuroinflammatory mechanisms in Parkinson's disease: potential environmental triggers, pathways, and targets for early therapeutic intervention Experimental Neurology 2007 208 1 1 25 (Pubitemid 47603240)
7. Gao H. M., Liu B., Zhang W. Q., Hong J. S., Critical role of microglial NADPH oxidase-derived free radicals in the in vitro MPTP model of Parkinson's disease FASEB Journal 2003 17 1954 1976
8. Lai K. N., Chan L. Y. Y., Tang S. C. W., Leung J. C. K., Ganoderma extract prevents albumin-induced oxidative damage and chemokines synthesis in cultured human proximal tubular epithelial cells Nephrology Dialysis Transplantation 2006 21 1188 1197
9. Lin J.-M., Lin C.-C., Chen M.-F., Ujiie T., Takada A., Radical scavenger and antihepatotoxic activity of Ganoderma formosanum, Ganoderma lucidum and Ganoderma neo-japonicum Journal of Ethnopharmacology 1995 47 1 33 41
10. Lindequist U., Niedermeyer T. H. J., Julich W. D., The pharmacological potential of mushrooms Evidence-Based Complementary and Alternative Medicine 2005 2 285 299 (Pubitemid 41258148)
11. Yuhong Y. O. U., Zhibin L. I. N., Protective effects of Ganodema lucidum polysaccharides peptide on injury of macrophages induced by reactive oxygen species Acta Pharmacologica Sinica 2002 23 787
12. Xiu-shu W., De-ming D., Protective effect of lingzhizongdai against nerve cell damnification Modern Medicine and Hygiene 2004 20 1576 1577
13. Le W.-D., Rowe D., Xie W., Ortiz I., He Y., Appel S. H., Microglial activation and dopaminergic cell injury: an in vitro model relevant to Parkinson's disease Journal of Neuroscience 2001 21 21 8447 8455 (Pubitemid 33051443)
14. Crawford G. D. Jr., Le W.-D., Smith R. G., Xie W.-J., Stefani E., Appel S. H., A novel N18TG2 x mesencephalon cell hybrid expresses properties that suggest a dopaminergic cell line of substantia nigra origin Journal of Neuroscience 1992 12 9 3392 3398
15. Gao H.-M., Hong J.-S., Zhang W., Liu B., Distinct role for microglia in rotenone-induced degeneration of dopaminergic neurons Journal of Neuroscience 2002 22 3 782 790 (Pubitemid 34141759)
16. Mayer A. M., Therapeutic implications of microglia activation by lipopolysaccharide and reactive oxygen species generation in septic shock and central nervous system pathologies: a review Medicina (B Aires) 1998 58 377 385 (Pubitemid 128519203)
17. Schell J. B., Crane C. A., Smith M. F. Jr., Roberts M. R., Differential ex vivo nitric oxide production by acutely isolated neonatal and adult microglia Journal of Neuroimmunology 2007 189 1-2 75 87 (Pubitemid 47379435)
18. Liu B., Du L., Hong J. S., Naloxone protects rat dopaminergic neurons against inflammatory damage through inhibition of microglia activation and superoxide generation Journal of Pharmacology and Experimental Therapeutics 2000 293 607 617 (Pubitemid 30244114)
19. Hanisch U.-K., Kettenmann H., Microglia: active sensor and versatile effector cells in the normal and pathologic brain Nature Neuroscience 2007 10 11 1387 1394 (Pubitemid 350014685)
20. Block M. L., Zecca L., Hong J.-S., Microglia-mediated neurotoxicity: uncovering the molecular mechanisms Nature Reviews Neuroscience 2007 8 1 57 69 (Pubitemid 46011999)
21. Fuxe K. G., Tarakanov A. O., Goncharova L. B., Agnati L. F., A new road to neuroinflammation in Parkinson's disease? Brain Research Reviews 2008 58 2 453 458
22. Rogove A. D., Tsirka S. E., Neurotoxic responses by microglia elicited by excitotoxic injury in the mouse hippocampus Current Biology 1998 8 1 19 25 (Pubitemid 28056250)
23. Wen L. L., Chiu C. T., Huang Y. N., Chang C. F., Wang J. Y., Rapid glia expression and release of proinflammatory cytokines in experimental Klebsiella pneumoniae meningoencephalitis Experimental Neurology 2007 205 270 278
24. Gao H.-M., Jiang J., Wilson B., Zhang W., Hong J.-S., Liu B., Microglial activation-mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: relevance to Parkinson's disease Journal of Neurochemistry 2002 81 6 1285 1297 (Pubitemid 34809262)
25. Persson M., Brantefjord M., Hansson E., Rnnbck L., Lipopolysaccharide increases microglial GLT-1 expression and glutamate uptake capacity in vitro by a mechanism dependent on TNF- GLIA 2005 51 2 111 120 (Pubitemid 41277345)
26. Taupin V., Renno T., Bourbonnire L., Peterson A. C., Rodriguez M., Owens T., Increased severity of experimental autoimmune encephalomyelitis, chronic macrophage/microglial reactivity, and demyelination in transgenic mice producing tumor necrosis factor- in the central nervous system European Journal of Immunology 1997 27 4 905 913 (Pubitemid 27153660)
27. Mosley R. L., Benner E. J., Kadiu I., Thomas M., Boska M. D., Hasan K., Laurie C., Gendelman H. E., Neuroinflammation, oxidative stress, and the pathogenesis of Parkinson's disease Clinical Neuroscience Research 2006 6 5 261 281 (Pubitemid 44849177)
28. Mander P. K., Jekabsone A., Brown G. C., Microglia proliferation is regulated by hydrogen peroxide from NADPH oxidase Journal of Immunology 2006 176 2 1046 1052 (Pubitemid 43099705)
29. Baeuerle P. A., Henkel T., Function and activation of NF-kappaB in the immune system Annual Review of Immunology 1994 12 141 179
30. Delhase M., Li N., Karin M., Ozes ON, Mayo L. D., Gustin J. A., Kinase regulation in inflammatory response. Authors' reply Nature 2000 406 367 368 (Pubitemid 30625546)
31. Block M. L., Hong J.-S., Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism Progress in Neurobiology 2005 76 2 77 98 (Pubitemid 41242883)
32. Teismann P., Tieu K., Cohen O., Choi D.-K., Wu D. C., Marks D., Vila M., Jackson-Lewis V., Przedborski S., Pathogenic role of glial cells in Parkinson's disease Movement Disorders 2003 18 2 121 129 (Pubitemid 36305454)
33. Kim Y. S., Kim S. S., Cho J. J., Choi D. H., Hwang O., Shin D. H., Chun H. S., Beal M. F., Joh T. H., Matrix metalloproteinase-3: a novel signaling proteinase from apoptotic neuronal cells that activates microglia Journal of Neuroscience 2005 25 14 3701 3711
34. Zhang W., Wang T., Pei Z., Miller D. S., Wu X., Block M. L., Wilson B., Zhang W., Zhou Y., Hong J.-S., Zhang J., Aggregated -synuclein activates microglia: a process leading to disease progression in Parkinson's disease FASEB Journal 2005 19 6 533 542 (Pubitemid 40471244)
35. Zecca L., Zucca F. A., Wilms H., Sulzer D., Neuromelanin of the substantia nigra: a neuronal black hole with protective and toxic characteristics Trends in Neurosciences 2003 26 11 578 580 (Pubitemid 37338363)
36. Carvey P. M., Chang Q., Lipton J. W., Ling Z., Prenatal exposure to the bacteriotoxin lipopolysaccharide leads to long-term losses of dopamine neurons in offspring: a potential, new model of Parkinson's disease Frontiers in Bioscience 2003 8 s826 s837 (Pubitemid 39140200)
37. Wu D. C., Jackson-Lewis V., Vila M., Tieu K., Teismann P., Vadseth C., Choi D.-K., Ischiropoulos H., Przedborski S., Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease Journal of Neuroscience 2002 22 5 1763 1771 (Pubitemid 35386294)
38. Yuen J. W. M., Gohel M. D. I., Anticancer effects of Ganoderma lucidum: a review of scientific evidence Nutrition and Cancer 2005 53 1 11 17 (Pubitemid 43068549)
39. Gao Y., Tang W., Dai X., Gao H., Chen G., Ye J., Effects of water-soluble Ganoderma lucidum polysaccharides on the immune functions of patients with advanced lung cancer Journal of Medicinal Food 2005 8 159 168 (Pubitemid 41008978)
40. Ajith T. A., Sudheesh N. P., Roshny D., Abishek G., Janardhanan K. K., Effect of Ganoderma lucidum on the activities of mitochondrial dehydrogenases and complex I and II of electron transport chain in the brain of aged rats Experimental Gerontology 2009 44 3 219 223
41. Boh B., Berovic M., Zhang J., Zhi-Bin L., Ganoderma lucidum and its pharmaceutically active compounds Biotechnology Annual Review 2007 13 265 301 (Pubitemid 47387127)
42. Pan T., Jankovic J., Le W., Potential therapeutic properties of green tea polyphenols in Parkinson's disease Drugs and Aging 2003 20 10 711 721 (Pubitemid 36995249)
43. Van Kampen J., Robertson H., Hagg T., Drobitch R., Neuroprotective actions of the ginseng extract G115 in two rodent models of Parkinson's disease Experimental Neurology 2003 184 1 521 529 (Pubitemid 37444059)
44. Kim M. S., Lee J. I., Lee W. Y., Kim S. E., Neuroprotective effect of Ginkgo biloba L. extract in a rat model of Parkinson's disease Phytotherapy Research 2004 18 663 666
45. Ebadi M., Srinivasan S. K., Baxi M. D., Oxidative stress and antioxidant therapy in Parkinson's disease Progress in Neurobiology 1996 48 1 1 19 (Pubitemid 26111215)
46. Radad K., Gille G., Moldzio R., Saito H., Ishige K., Rausch W.-D., Ginsenosides Rb1 and Rg1 effects on survival and neurite growth of MPP +-affected mesencephalic dopaminergic cells Journal of Neural Transmission 2004 111 1 37 45 (Pubitemid 38177816)